Literature DB >> 9644644

Silent infection in clotted hemodialysis access grafts.

J C Ayus1, D Sheikh-Hamad.   

Abstract

Thrombotic and infectious complications are frequent causes of hemodialysis vascular access failure and contribute considerably to the cost of care for chronic hemodialysis patients. Although there is clear indication for removal of patent grafts in unresolved bacteremia, there are no guidelines for the management of clotted nonfunctioning grafts. To evaluate for the existence and clinical relevance of silent infection in clotted nonfunctioning hemodialysis grafts, a study was conducted with a series of 20 hemodialysis patients who presented with fever (15 patients), or fever and clinical signs of sepsis (five patients), in whom the source of infection was not immediately localized to any organ system. Comparison was made with 21 asymptomatic patients with clotted grafts who served as control subjects. All patients and control subjects came from a pool of 115 chronic hemodialysis patients in an outpatient hemodialysis unit in the Houston metropolitan area, who were on hemodialysis for a period of time ranging from 3 to 15 yr. Indium scans were performed, followed by removal of the clotted grafts in all patients and control subjects. Bacterial cultures of the recovered surgical material and blood were done concomitantly in all study participants. Indium scans showed positive uptake in or around the clotted grafts in all of the patients and in 15 of the control subjects. Purulent material was found in the grafts in all patients and in 13 of 15 indium scan-positive control subjects. When positive, blood culture pathogens were identical to those cultured from the graft material in all instances. The predominant pathogens were Staphylococcus aureus, followed by Staphylococcus epidermidis. There was no evidence of graft infection in the control subjects if indium scan was negative. Chart review dating back to the start of dialysis revealed five past infectious episodes in the patient group, compared with four in the control group. These findings suggest that clotted nonfunctioning grafts are frequent harbingers of infection. They should be suspected as the source of infection in every hemodialysis patient that presents with fever, even in the absence of clinical signs of graft site infection.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9644644     DOI: 10.1681/ASN.V971314

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  9 in total

1.  Enterobacter cloacae infection of an expanded polytetrafluoroethylene femoral-popliteal bypass graft: a case report.

Authors:  Ian Musil; Vanessa Jensen; Jolyon Schilling; Boyd Ashdown; Tyler Kent
Journal:  J Med Case Rep       Date:  2010-05-09

2.  Vascular access type, inflammatory markers, and mortality in incident hemodialysis patients: the Choices for Healthy Outcomes in Caring for End-Stage Renal Disease (CHOICE) Study.

Authors:  Tanushree Banerjee; S Joseph Kim; Brad Astor; Tariq Shafi; Josef Coresh; Neil R Powe
Journal:  Am J Kidney Dis       Date:  2014-09-27       Impact factor: 8.860

Review 3.  A practical review of the use of stents for the maintenance of hemodialysis access.

Authors:  Michael Ginsburg; Jonathan M Lorenz; Sean P Zivin; Steven Zangan; Don Martinez
Journal:  Semin Intervent Radiol       Date:  2015-06       Impact factor: 1.513

4.  C-reactive protein levels in patients on maintenance hemodialysis: reliability and reflection on the utility of single measurements.

Authors:  Caroline E Stigant; Ognjenka Djurdjev; Adeera Levin
Journal:  Int Urol Nephrol       Date:  2005       Impact factor: 2.370

5.  Long-term effects of daily hemodialysis on vascular access outcomes: a prospective controlled study.

Authors:  Steven G Achinger; T Alp Ikizler; Aihua Bian; Ayumi Shintani; Juan Carlos Ayus
Journal:  Hemodial Int       Date:  2012-09-28       Impact factor: 1.812

6.  Accumulation of retained nonfunctional arteriovenous grafts correlates with severity of inflammation in asymptomatic ESRD patients.

Authors:  Haimanot Wasse; Francesca Cardarelli; Christine De Staercke; W Craig Hooper; Qi Long
Journal:  Nephrol Dial Transplant       Date:  2012-10-22       Impact factor: 5.992

7.  Associations of interleukin-6, C-reactive protein and serum amyloid A with mortality in haemodialysis patients.

Authors:  James B Wetmore; David H Lovett; Adriana M Hung; Galen Cook-Wiens; Jonathan D Mahnken; Saunak Sen; Kirsten L Johansen
Journal:  Nephrology (Carlton)       Date:  2008-09-25       Impact factor: 2.506

8.  Transplant nephrectomy improves survival following a failed renal allograft.

Authors:  Juan Carlos Ayus; Steven G Achinger; Shuko Lee; Mohamed H Sayegh; Alan S Go
Journal:  J Am Soc Nephrol       Date:  2009-10-29       Impact factor: 10.121

9.  Pretransplantation erythropoiesis-stimulating agent hyporesponsiveness is associated with increased kidney allograft failure and mortality.

Authors:  Nadiesda A Costa; Abhijit V Kshirsagar; Lily Wang; Randal K Detwiler; M Alan Brookhart
Journal:  Transplantation       Date:  2013-11-15       Impact factor: 4.939

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.